HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-30
DOI
10.3389/fendo.2018.00715
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease PatientsHighlights
- (2018) Andreas Gille et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis
- (2018) Pingting Zhou et al. CLINICA CHIMICA ACTA
- High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation
- (2018) Massimiliano Ruscica et al. Scientific Reports
- Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting
- (2017) Jie Tang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression
- (2017) Meiyu Peng et al. Oncotarget
- High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
- (2016) Rui Kuai et al. ACS Nano
- Lipid biomarkers and long-term risk of cancer in the Women’s Health Study
- (2016) Paulette D Chandler et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity
- (2016) Carolyne K Smith et al. ANNALS OF THE RHEUMATIC DISEASES
- Synthetic High-Density Lipoprotein (sHDL) Inhibits Steroid Production in HAC15 Adrenal Cells
- (2016) Matthew J. Taylor et al. ENDOCRINOLOGY
- Lipid Raft Integrity Is Required for Survival of Triple Negative Breast Cancer Cells
- (2016) Anil Badana et al. Journal of Breast Cancer
- Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization
- (2016) Jie Tang et al. JOURNAL OF LIPID RESEARCH
- The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma
- (2016) Shengjie Guo et al. MEDICINE
- Up-regulated expression of scavenger receptor class B type 1 (SR-B1) is associated with malignant behaviors and poor prognosis of breast cancer
- (2016) Juan Li et al. PATHOLOGY RESEARCH AND PRACTICE
- Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas
- (2016) Chitra Subramanian et al. SURGERY
- ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
- (2016) Lídia Cedó et al. Scientific Reports
- Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
- (2016) Linda K. Mooberry et al. Frontiers in Pharmacology
- SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer
- (2016) Jorge L. Gutierrez-Pajares et al. Frontiers in Pharmacology
- Lipid metabolic reprogramming in cancer cells
- (2016) S Beloribi-Djefaflia et al. Oncogenesis
- The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory
- (2015) Ryan Namiri-Kalantari et al. BIOFACTORS
- Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies
- (2015) Mathilde Touvier et al. BRITISH JOURNAL OF NUTRITION
- Targeting cholesterol with β-cyclodextrin sensitizes cancer cells for apoptosis
- (2015) Ryuji Yamaguchi et al. FEBS LETTERS
- Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
- (2015) Tomáš Vaisar et al. JOURNAL OF LIPID RESEARCH
- The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties
- (2015) Anna Schwendeman et al. JOURNAL OF LIPID RESEARCH
- Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
- (2015) L. J. Martin et al. JNCI-Journal of the National Cancer Institute
- Dysfunctional HDL and atherosclerotic cardiovascular disease
- (2015) Robert S. Rosenson et al. Nature Reviews Cardiology
- High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer
- (2015) Baoying Yuan et al. TUMOR BIOLOGY
- Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
- (2015) L. J. Martin et al. JNCI-Journal of the National Cancer Institute
- Highly Selective Anti-Cancer Activity of Cholesterol-Interacting Agents Methyl-β-Cyclodextrin and Ostreolysin A/Pleurotolysin B Protein Complex on Urothelial Cancer Cells
- (2015) Nataša Resnik et al. PLoS One
- APOA1 mRNA Expression in Ovarian Serous Carcinoma Effusions Is a Marker of Longer Survival
- (2014) Helene Tuft Stavnes et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease
- (2014) A. Kratzer et al. CARDIOVASCULAR RESEARCH
- HDL Cholesterol and Cancer Risk Among Patients With Type 2 Diabetes
- (2014) Wenhui Zhao et al. DIABETES CARE
- Synthetic high-density lipoprotein-like nanoparticles for cancer therapy
- (2014) Linda Foit et al. Expert Review of Anticancer Therapy
- Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology
- (2014) Ruth Birner-Gruenberger et al. PROGRESS IN LIPID RESEARCH
- Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: A focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays
- (2013) Semjon Willier et al. BIOLOGY OF THE CELL
- Reconstituted HDL for the acute treatment of acute coronary syndrome
- (2013) Brian R. Krause et al. CURRENT OPINION IN LIPIDOLOGY
- The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects
- (2013) Maryam Zamanian-Daryoush et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A multiple ascending dose study of CSL112, an infused formulation of ApoA-I
- (2013) Rachael Easton et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Unraveling the complexities of the HDL lipidome
- (2013) Anatol Kontush et al. JOURNAL OF LIPID RESEARCH
- Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
- (2013) Amy S. Shah et al. JOURNAL OF LIPID RESEARCH
- Cardioprotective functions of HDLs
- (2013) Kerry-Anne Rye et al. JOURNAL OF LIPID RESEARCH
- Scavenger Receptor B1 is a Potential Biomarker of Human Nasopharyngeal Carcinoma and Its Growth is Inhibited by HDL-mimetic Nanoparticles
- (2013) Ying Zheng et al. Theranostics
- The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics
- (2013) Pedro M. R. Cruz et al. Frontiers in Pharmacology
- HDL of Patients with Type 2 Diabetes Mellitus Elevates the Capability of Promoting Breast Cancer Metastasis
- (2012) Bing Pan et al. CLINICAL CANCER RESEARCH
- Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis
- (2012) Bing Pan et al. Journal of Translational Medicine
- HDL Mimetics Inhibit Tumor Development in Both Induced and Spontaneous Mouse Models of Colon Cancer
- (2012) Feng Su et al. MOLECULAR CANCER THERAPEUTICS
- Development of Multiplexed Bead-Based Immunoassays for the Detection of Early Stage Ovarian Cancer Using a Combination of Serum Biomarkers
- (2012) Yong-Wan Kim et al. PLoS One
- The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins
- (2011) Belinda A. Di Bartolo et al. ATHEROSCLEROSIS
- The HDL proteome in acute coronary syndromes shifts to an inflammatory profile
- (2011) Khalid Alwaili et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study
- (2011) Mieke Van Hemelrijck et al. CANCER CAUSES & CONTROL
- Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer
- (2011) Charlotte H. Clarke et al. GYNECOLOGIC ONCOLOGY
- L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways
- (2011) Feng Gao et al. Integrative Biology
- Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea
- (2011) Cari M. Kitahara et al. JOURNAL OF CLINICAL ONCOLOGY
- Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
- (2011) Atul Purohit et al. JOURNAL OF ENDOCRINOLOGY
- Baseline and On-Treatment High-Density Lipoprotein Cholesterol and the Risk of Cancer in Randomized Controlled Trials of Lipid-Altering Therapy
- (2010) Haseeb Jafri et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen-Independent Cancer Cells by an ABCA1-Dependent Mechanism
- (2010) Y. Sekine et al. MOLECULAR CANCER RESEARCH
- Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones
- (2010) Jie Hu et al. Nutrition & Metabolism
- The Pathologic Classification of Neuroendocrine Tumors
- (2010) David S. Klimstra et al. PANCREAS
- Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
- (2010) F. Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer
- (2009) J. Ahn et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- HDL as a Biomarker, Potential Therapeutic Target, and Therapy: FIG. 1.
- (2009) Mohamad Navab et al. DIABETES
- HDL-Cholesterol and Incidence of Breast Cancer in the ARIC Cohort Study
- (2008) Anna M. Kucharska-Newton et al. ANNALS OF EPIDEMIOLOGY
- The HDL proteome: a marker–and perhaps mediator–of coronary artery disease: Fig. 1.
- (2008) Jay W. Heinecke JOURNAL OF LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now